Skip to main content
OpenTrials

Clinical trial condition

MPN (Myeloproliferative Neoplasms)

Explore clinical trials studying MPN (Myeloproliferative Neoplasms). Study availability and eligibility vary by location and protocol.

9 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

MPN (Myeloproliferative Neoplasms) trial results

Completed

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - (FIGHT-203)

NCT03011372

Conditions
Bone Marrow Diseases, Eosinophilia, Hematologic Diseases, +4 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Emory University - Winship Cancer Institute Atlanta, Georgia, United States
View all 33 locations
View Trial Details
Completed

A Study of Itacitinib in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Participants With Myelofibrosis

NCT03144687

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Arizona Oncology Associates Tempe, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • Anschutz Cancer Pavilion - University Of Colorado Aurora, Colorado, United States
  • Rocky Mountain Cancer Center Colorado Springs, Colorado, United States
View all 26 locations
View Trial Details
Completed

An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis

NCT01633372

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Birmingham Hematology Oncology Associates, LLC Birmingham, Alabama, United States
  • Mayo Clinic, Arizona Scottsdale, Arizona, United States
  • UCLA Hematology & Oncology Los Angeles, California, United States
  • Emory University Atlanta, Georgia, United States
View all 22 locations
View Trial Details
Completed

Ruxolitinib (INCB018424) in Participants With Primary Myelofibrosis (PMF), Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis (PPV-MF)

NCT01348490

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Birmingham, Alabama, United States
  • Beverly Hills, California, United States
  • Burbank, California, United States
  • La Jolla, California, United States
View all 38 locations
View Trial Details

Related conditions